Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marwa Hassan Shukr"'
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 1762-1769 (2017)
Duloxetine hydrochloride (DH) is a serotonin–norepinephrine reuptake inhibitor (SSNRI) indicated for the treatment of depression. Duloxetine suffers from reduced oral bioavailability (≈50%) due to hepatic metabolism. This study aims to develop DH
Externí odkaz:
https://doaj.org/article/a4041f920b4147f2977484ad2f50ba77
Publikováno v:
Journal of Drug Delivery Science and Technology. 52:282-291
Duloxetine hydrochloride (DH) is a serotonin-norepinephrine reuptake inhibitor (SSNRI) indicated for the treatment of depression. Duloxetine suffers from reduced oral bioavailability (≈50%) due to hepatic metabolism. DH buccoadhesive lyophilized ta
Publikováno v:
Journal of Drug Delivery Science and Technology. 49:383-395
The current study aims to develop and optimize ezetimibe chitosan nanoparticles by using 22.31 factorial design, where chitosan: tripolyphosphate (TPP) ratio (X1), molecular weight of chitosan (X2) and drug concentration (X3) were chosen as independe
Publikováno v:
Pharmaceutical development and technology. 26(4)
Intranasal drug delivery system has been proposed as an alternative delivery system to target agomelatine (AGO) to the brain and improving its bioavailability. Mucoadhesive egg lecithin nanoemulsions were optimized using D-optimal design and by inves
Publikováno v:
Journal of pharmaceutical sciences. 109(7)
Vascular dementia is a condition characterized by a wretched cerebral circulation which can lead to memory loss. Vinpocetine showed ability to promote the cerebral circulation and depict neuroprotective impacts. However, it suffers from poor bioavail
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery, Vol 24, Iss 1, Pp 1762-1769 (2017)
article-version (VoR) Version of Record
Drug Delivery, Vol 24, Iss 1, Pp 1762-1769 (2017)
Duloxetine hydrochloride (DH) is a serotonin–norepinephrine reuptake inhibitor (SSNRI) indicated for the treatment of depression. Duloxetine suffers from reduced oral bioavailability (≈50%) due to hepatic metabolism. This study aims to develop DH
Publikováno v:
Journal of Drug Delivery Science and Technology. 61:102333
Travoprost (TRAVO) is a prostaglandin analog used to reduce the intraocular pressure (IOP) for patients suffering from glaucoma and ocular hypertension. The aim of the present study was the development of a novel in situ mucoadhesive ocular liposomal
Autor:
Marwa Hassan Shukr
Publikováno v:
Journal of Microencapsulation. 33:71-79
This work aimed to develop voriconazole in situ gelling ocular inserts loaded with niosomal suspension. Niosomes and mixed niosomes were prepared using span 40 and span 60 with pluronic L64 and pluronic F127. The entrapment efficiency percentages (EE
Publikováno v:
Journal of Drug Delivery Science and Technology. 58:101806
Sucrose acetate isobutyrate based nanovesicles (SBN) were designed to enhance the Ticagrelor poor bioavailability (36%). SBN were formulated with different ratios of sucrose acetate isobutyrate and Poloxamer 407 and tested for particle size, polydisp
Publikováno v:
Journal of pharmaceutical sciences. 108(2)
Ion cross-linking in situ gels are novel liquid sustained-release drug delivery systems. These systems are unsuitable for poorly water-soluble drugs such as the novel antidiabetic drug mitiglinide calcium (MTG). Thus, our goal was to assess the possi